Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Capital Expenditures (2020 - 2025)

Zai Lab's Capital Expenditures history spans 6 years, with the latest figure at $677000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 73.96% year-over-year to $677000.0; the TTM value through Dec 2025 reached $8.1 million, up 43.2%, while the annual FY2025 figure was $8.1 million, 43.2% up from the prior year.
  • Capital Expenditures for Q4 2025 was $677000.0 at Zai Lab, down from $3.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $9.7 million in Q1 2022 and bottomed at $222000.0 in Q4 2023.
  • The 5-year median for Capital Expenditures is $2.7 million (2024), against an average of $3.2 million.
  • The largest annual shift saw Capital Expenditures surged 1424.62% in 2021 before it plummeted 94.97% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $6.4 million in 2021, then crashed by 30.81% to $4.4 million in 2022, then tumbled by 94.97% to $222000.0 in 2023, then soared by 1071.17% to $2.6 million in 2024, then plummeted by 73.96% to $677000.0 in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Capital Expenditures are $677000.0 (Q4 2025), $3.0 million (Q3 2025), and $2.9 million (Q2 2025).